Parsec Financial Management, Inc. Myriad Genetics Inc Transaction History

Parsec Financial Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Jul 26, 2018	SELL	$27.75 - $40.17 $847,179 - $1.23 Million	-30,529 Closed	0 $0
Q1 2018 Apr 25, 2018	SELL	$28.83 - $41.01 $48,463 - $68,937	-1,681 Reduced 5.22%	30,529 $902,000
Q4 2017 Jan 26, 2018	SELL	$28.45 - $37.14 $6,828 - $8,913	-240 Reduced 0.74%	32,210 $1.11 Million
Q3 2017 Oct 25, 2017	BUY	$24.01 - $36.2 $779,124 - $1.17 Million	32,450	32,450 $1.17 Million

227

85.9M

297K

20.7K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $652M
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Parsec Financial Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Parsec Financial Management, Inc. with notifications on news.